Big Roadblocks To Avoid When Implementing A New CTMS

Clinical trials are becoming more intricate and extensive, leading to noticeable effects on the duration and expenses involved. Despite the adoption of hybrid trial designs and new technologies, more than 50% of research sites still report challenges with enrolling an adequate number of participants. To overcome these hurdles, sponsors and contract research organizations (CROs) have turned to more advanced technologies, such as clinical trial management systems (CTMS). By leveraging CTMS, trial operations can be streamlined, site performance can be enhanced, and the administrative workload can be reduced.

To successfully implement a new CTMS, various stakeholders will need to be willing to stay actively involved and cooperate with one another throughout the process. Failing to invest adequate time initially to comprehend and address potential obstacles can result in disruptions to workflows and low user acceptance. Nonetheless, through proper planning, access to relevant expertise, and the right technology, organizations can expedite the implementation and adoption of CTMS, thereby achieving a quicker return on investment.

Watch the full webinar to discover the most common roadblocks customers face when adopting a modern CTMS—and how to avoid them. Moderated by Life Science Connect Host Miles Szkoda, Medidata's Vice President of Product Management, CTMS, Martin Dowdall, and Director of Solution Services (CTMS & CTFM) Tara Adrian discuss:

• The top challenges organizations face when implementing CTMS, including integration and change management
• Recommendations to overcome roadblocks, including a technology and implementation checklist to make sure you avoid those challenges
• Best practices on how to ensure successful adoption by end users